中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

17 records (took 0.025 seconds)

    Method for preparation of fine powdered cellulose ethers
    11.
    发明申请
    Method for preparation of fine powdered cellulose ethers 审中-公开
    纤维素微粉的制备方法

    公开(公告)号：US20070093656A1

    公开(公告)日：2007-04-26

    申请号：US10582743

    申请日：2003-12-29

    Applicant: Seok Soo Kim ,  Jung Ho So ,  Sang Ku Lee ,  II Yong Lee ,  Myung Cho ,  kyoung Yun

    Inventor： Seok Soo Kim ,  Jung Ho So ,  Sang Ku Lee ,  II Yong Lee ,  Myung Cho ,  kyoung Yun

    IPC: C08B11/08

    CPC classification number: C08B11/00 ,  C08B11/02 ,  C08B11/08 ,  C08B11/193

    Abstract: The present invention relates to a method for preparing fine powdered cellulose ethers. In particular, the present invention relates to a method for preparing cellulose ethers in a cost-effective manner having high running efficiency of process, which comprises specifically regulating a reaction condition of each step to induce a particle refinement and significantly reduce a running load on a grinding process, in the reaction of treating finely pulverized celluloses with a caustic soda and reacting with an etherifying agent.

    Abstract translation: 本发明涉及一种制备细粉状纤维素醚的方法。 特别地，本发明涉及以具有高工艺运行效率的成本有效的方式制备纤维素醚的方法，该方法包括特别地调节每个步骤的反应条件以诱导颗粒细化并显着减少在 在将精细粉碎的纤维素与苛性钠一起处理并与醚化剂反应的反应中进行。

    WATER TREATMENT APPARATUS INTEGRATED WITH WATER METER USING MAGNET
    13.
    发明申请
    WATER TREATMENT APPARATUS INTEGRATED WITH WATER METER USING MAGNET 审中-公开
    水处理装置与水表一起使用磁铁

    公开(公告)号：US20140008275A1

    公开(公告)日：2014-01-09

    申请号：US13686937

    申请日：2012-11-28

    Applicant: Sang Ku LEE

    Inventor： Sang Ku LEE

    IPC: C02F1/48

    CPC classification number: C02F1/48 ,  C02F1/481 ,  C02F2201/483 ,  C02F2301/026

    Abstract: A water meter integrated water treatment apparatus. At least one coil spring is disposed inside at least one of water pipes which are connected to both sections of a water meter. The coil spring is in close contact with an inner diameter surface of the water pipe. At least two magnets are disposed inside and in close contact with an inner diameter surface of the coil spring. An interval is formed between the magnets in a longitudinal direction of the water pipe. The inner diameter surface of the water pipe, the coil spring and the magnets are in close and sealing contact with each other, thereby forming a water passage through which water flows. Tap water that is to be introduced into a building through the water meter can be magnetized (ionized).

    Abstract translation: 水表综合水处理设备。 至少一个螺旋弹簧设置在与水表的两个部分连接的至少一个水管内。 螺旋弹簧与水管的内径表面紧密接触。 至少两个磁体设置在内部并与螺旋弹簧的内径表面紧密接触。 在水管的长度方向上在磁体之间形成间隔。 水管，螺旋弹簧和磁体的内径表面彼此紧密地密封接触，从而形成水流通过的水通道。 通过水表引入建筑物的自来水可以被磁化（电离）。

    3,4-dihydroxyhydrocinnamic acid derivative
    14.
    发明授权
    3,4-dihydroxyhydrocinnamic acid derivative 失效
    3,4-二羟基氢化肉桂酸衍生物

    公开(公告)号：US07192981B2

    公开(公告)日：2007-03-20

    申请号：US11079888

    申请日：2005-03-14

    Applicant: Song-Hae Bok ,  Eun-Eai Kim ,  Sang-Ku Lee ,  Ji-Won Yoon ,  Hee-Sook Jeon ,  Lee-Yong Khil ,  Wi Kim

    Inventor： Song-Hae Bok ,  Eun-Eai Kim ,  Sang-Ku Lee ,  Ji-Won Yoon ,  Hee-Sook Jeon ,  Lee-Yong Khil ,  Wi Kim

    IPC: A61K31/235 ,  C07C69/76

    CPC classification number: C07C69/732

    Abstract: According to the invention, there is provided a novel 3,4-dihydroxyhydrocinnamic acid derivative, designated DHH105, having blood glucose lowering effects in vivo as a result of the enhancement of glucose transport mediated by the increase of insulin receptor signaling.This invention thus relates to a 3,4-dihydroxyhydrocinnamic acid derivative useful as an anti-diabetic agent, represented by the following formula I: or pharmaceutically acceptable salts thereof, to a method for preparing the compound, and to a composition for treating diabetes comprising the same as an active ingredient.

    Abstract translation: 根据本发明，提供了由于胰岛素受体信号传导的增加介导的葡萄糖转运增加而在体内具有降血糖作用的新型3,4-二氢羟基肉桂酸衍生物，命名为DHH105。 因此，本发明涉及作为抗化学药剂的3,4-二羟基氢肉桂酸衍生物，其用作下列通式I所示的抗糖尿病药或其药学上可接受的盐，涉及制备该化合物的方法，以及涉及用于治疗糖尿病的组合物， 与活性成分相同。

    Novel 3,4-dihydroxyhydrocinnamic acid derivative
    15.
    发明申请
    Novel 3,4-dihydroxyhydrocinnamic acid derivative 失效
    新型3,4-二羟基氢化肉桂酸衍生物

    公开(公告)号：US20060205813A1

    公开(公告)日：2006-09-14

    申请号：US11079888

    申请日：2005-03-14

    Applicant: Song-Hae Bok ,  Eun-Eai Kim ,  Sang-Ku Lee ,  Ji-Won Yoon ,  Hee-Sook Jeon ,  Lee-Yong Khil ,  Wi Kim

    Inventor： Song-Hae Bok ,  Eun-Eai Kim ,  Sang-Ku Lee ,  Ji-Won Yoon ,  Hee-Sook Jeon ,  Lee-Yong Khil ,  Wi Kim

    IPC: A61K31/235 ,  C07C69/76

    CPC classification number: C07C69/732

    Abstract: According to the invention, there is provided a novel 3,4-dihydroxyhydrocinnamic acid derivative, designated DHH105, having blood glucose lowering effects in vivo as a result of the enhancement of glucose transport mediated by the increase of insulin receptor signaling. This invention thus relates to a 3,4-dihydroxyhydrocinnamic acid derivative useful as an anti-diabetic agent, represented by the following formula I: or pharmaceutically acceptable salts thereof, to a method for preparing the compound, and to a composition for treating diabetes comprising the same as an active ingredient.

    Abstract translation: 根据本发明，提供了由于胰岛素受体信号传导的增加介导的葡萄糖转运增加而在体内具有降血糖作用的新型3,4-二氢羟基肉桂酸衍生物，命名为DHH105。 因此，本发明涉及作为抗化学药剂的3,4-二羟基氢肉桂酸衍生物，其用作下列通式I所示的抗糖尿病药或其药学上可接受的盐，涉及制备该化合物的方法，以及涉及用于治疗糖尿病的组合物， 与活性成分相同。

    Flavanone derivatives and composition for preventing or treating blood lipid level-related diseases comprising same
    17.
    发明授权
    Flavanone derivatives and composition for preventing or treating blood lipid level-related diseases comprising same 失效
    用于预防或治疗包含其的血脂水平相关疾病的黄酮酮衍生物和组合物

    公开(公告)号：US06455577B2

    公开(公告)日：2002-09-24

    申请号：US09768740

    申请日：2001-01-24

    Applicant: Song-Hae Bok ,  Tae-Sook Jeong ,  Sang-Ku Lee ,  Ju-Ryong Kim ,  Surk-Sik Moon ,  Myung-Sook Choi ,  Byung-Hwa Hyun ,  Chul-Ho Lee ,  Yang-Kyu Choi

    Inventor： Song-Hae Bok ,  Tae-Sook Jeong ,  Sang-Ku Lee ,  Ju-Ryong Kim ,  Surk-Sik Moon ,  Myung-Sook Choi ,  Byung-Hwa Hyun ,  Chul-Ho Lee ,  Yang-Kyu Choi

    IPC: A61K3135

    CPC classification number: A23L2/52 ,  A23L13/42 ,  A23L27/63 ,  A23L33/105 ,  A23V2002/00 ,  C07D311/32 ,  A23V2250/2116

    Abstract: A compound of formula (I) treating or preventing an elevated blood lipid level-related disease and inhibiting the activities of acyl-CoA:cholesterol-O-acyltransferase(ACAT) and 3-hydroxy-3-methylglutaryl CoA(HMG-CoA) reductase: wherein, R1 is R5 R6CO group; R2 is H or R6CO group; R3 is H, CH3, R5 or R6CO group; R4 is H, OH, OR5 or R6COO group; R5 is a C2-5 alkyl group substituted with a phenyl group optionally having one or more substituents selected from the group consisting of C1-3 alkyl, OH, Cl and NO2; a C1-5 alkyl group substituted with a naphthyl group optionally having one or more substituents selected from the group consisting of C1-3 alkyl, OH, Cl and NO2; a C10-18 alkyl; or a C10-18 alkenyl group; and R6 is a C10-18 alkenyl group; or an aryl group optionally having one or more substituents selected from the group consisting of C1-3 alkyl, OH, Cl or NO2.

    Abstract translation: 治疗或预防血脂水平升高相关疾病和抑制酰基辅酶A：胆固醇-O-酰基转移酶（ACAT）和3-羟基-3-甲基戊二酰辅酶A（HMG-CoA）还原酶活性的式（I）化合物 其中，R1为R5 R6CO基; R2为H或R6CO基; R3为H，CH3，R5或R6CO基; R4为H，OH，OR5或R6COO基; R5为被苯基取代的C2-5烷基 基团任选具有一个或多个选自C 1-3烷基，OH，Cl和NO 2的取代基; 被任选具有一个或多个选自C 1-3烷基，OH，Cl和NO 2的取代基的萘基取代的C 1-5烷基; C10-18烷基; 或C 10-18烯基; 和R6是C10-18烯基; 或任选具有一个或多个选自C 1-3烷基，OH，Cl或NO 2的取代基的芳基。

Patent Agency Ranking